This HTML5 document contains 58 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n10http://dx.doi.org/10.2174/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37704499
rdf:type
wikibase:Item
schema:description
مقالة علمية نشرت في مارس 2010 wissenschaftlicher Artikel articolo scientifico article científic artigo científico vědecký článek videnskabelig artikel wetenschappelijk artikel vedecký článok bilimsel makale наукова стаття, опублікована в березні 2010 vetenskaplig artikel scientific article published on March 2010 artículu científicu espublizáu en 2010 научни чланак article scientifique
p:P577
wds:Q37704499-09288FA3-9129-4EA2-9903-BB7823F3E8C2
wdt:P577
2010-03-01T00:00:00Z
rdfs:label
CDK inhibitors: from the bench to clinical trials. CDK inhibitors: from the bench to clinical trials. CDK inhibitors: from the bench to clinical trials.
skos:prefLabel
CDK inhibitors: from the bench to clinical trials. CDK inhibitors: from the bench to clinical trials. CDK inhibitors: from the bench to clinical trials.
schema:name
CDK inhibitors: from the bench to clinical trials. CDK inhibitors: from the bench to clinical trials. CDK inhibitors: from the bench to clinical trials.
p:P50
wds:Q37704499-27415DAF-6810-4CD4-9B51-E87D1B54C768 wds:Q37704499-4C905611-3116-4999-ACC2-4F926A3D7850 wds:Q37704499-FB3FFE80-575C-4F1E-B378-54C7D8B520CC wds:Q37704499-D7C0C45A-8303-48C4-B2BD-3FCC2373017A wds:Q37704499-F20AC49A-3B4B-46AE-97E4-79506599DF40
wdt:P50
wd:Q57837360 wd:Q4776661 wd:Q57544256 wd:Q91429434 wd:Q46649928
p:P1476
wds:Q37704499-8C15BF68-E86D-419A-811A-F0F5B7B60ACB
wdt:P1476
CDK inhibitors: from the bench to clinical trials
p:P304
wds:Q37704499-22F3E9C9-DBD0-462F-AE81-FD6B92D8E712
wdt:P304
279-290
p:P31
wds:Q37704499-be09e457-4e5a-441b-b713-ce0634acd22e wds:Q37704499-1C4B997B-3749-4B95-832F-EEE0CC6270AC
wdt:P31
wd:Q7318358 wd:Q13442814
p:P698
wds:Q37704499-AFFFEC0A-C1D0-454F-B63B-6B4AC9CB1193
wdtn:P698
n11:20210753
wdt:P698
20210753
p:P1433
wds:Q37704499-F014C10F-0EDD-438C-A28F-02EFC527D49D
wdt:P1433
wd:Q15724627
p:P433
wds:Q37704499-D0920C37-4DEF-450E-81E5-9881E5B4C781
p:P478
wds:Q37704499-792E1AB3-077E-46FA-BD90-A0C248C361AE
wdt:P433
3
wdt:P478
11
p:P356
wds:Q37704499-6DC406FF-AA23-4D01-AA86-26DC7295C33D
wdtn:P356
n10:138945010790711978
wdt:P356
10.2174/138945010790711978